Medtronic PLC signed a $3.5 billion debt agreement to replace an old credit contract.

The Irish medical device maker said the $3.5 billion five-year unsecured revolving credit facility, which is subject to extensions, will be used for general corporate purposes, including as a backstop for the company's $3.5 billion commercial paper program.

Bank of America NA acted as administrative agent for the transaction.